Skip to main content
Premium Trial:

Request an Annual Quote

North Carolina to Launch Genomics Consortium

NEW YORK, Dec 15 – The North Carolina Biotechnology Center said Friday it would launch a new initiative to bring genomics professionals from the state’s universities, companies, and non-for-profit groups together in an effort to help coordinate projects and uncover opportunities for strategic alliances.

“In North Carolina there are a lot of people working on genomics, bioinformatics, and proteomics but they don’t always know what’s being done around the state,” said Barry Teater, director of corporate communications at the North Carolina Biotechnology Center. “This is an effort to unite them.”

Some nine non-for-profit organizations, 11 universities, and 16 companies, including Glaxo Wellcome and IBM, have already joined the consortium, Teater said.

He said that North Carolina would invest in the initiative, although the size of the investment has not yet been determined.

The consortium would run a website and hold regular monthly meeting for its members, he said. The group might also conduct lobbying efforts.

North Carolina Governor Jim Hunt will announce the initiative at the North Carolina Biotechnology Center on Monday at 4 p.m.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.